Docetaxel and Sirolimus in Patients With Advanced Malignancies

NCT01054313 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

103

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Docetaxel (Taxotere)
DRUG: Sirolimus (Rapamycin)
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center